Kim EJ - Search Results

1

Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.

Kwon D, Chae JB, Park CW, Kim YS, Lee SM, Kim EJ, Huh IH, Kim DY, Cho KD. Kwon D, et al. Among authors: kim ej, kim dy, kim ys. Arzneimittelforschung. 2001;51(3):204-13. doi: 10.1055/s-0031-1300026. Arzneimittelforschung. 2001. PMID: 11304936

2

General pharmacology of IY-81149, a new proton pump inhibitor.

Kim EJ, Lee RK, Lee SM, Kim DY. Kim EJ, et al. Among authors: kim dy. Arzneimittelforschung. 2001 Jan;51(1):51-9. doi: 10.1055/s-0031-1300002. Arzneimittelforschung. 2001. PMID: 11215326

3

A plasmid responsible for malonate assimilation in Pseudomonas fluorescens.

Kim YS, Kim EJ. Kim YS, et al. Among authors: kim ej. Plasmid. 1994 Sep;32(2):219-21. doi: 10.1006/plas.1994.1058. Plasmid. 1994. PMID: 7846146

4

Mid-trimester amniotic fluid pro-inflammatory biomarkers predict the risk of spontaneous preterm delivery in twins: a retrospective cohort study.

Lee SM, Park JS, Norwitz ER, Oh S, Kim EJ, Kim SM, Lee J, Kim BJ, Park CW, Jun JK. Lee SM, et al. Among authors: kim ej, kim bj, kim sm. J Perinatol. 2015 Aug;35(8):542-6. doi: 10.1038/jp.2015.29. Epub 2015 Apr 9. J Perinatol. 2015. PMID: 25856763

5

General pharmacology of the new antiviral agent SK 1899.

Ryu KH, Rhee HI, Jung I, Kim TS, Lee SJ, Im GJ, Lee N, Ryu DH, Kim YW, Kim JJ, Chang K, Lee BH, Shin HS, Kim EJ, Kim KH, Kim DK. Ryu KH, et al. Among authors: kim ts, kim jj, kim ej, kim dk, kim kh, kim yw. Arzneimittelforschung. 2000 Apr;50(4):395-403. doi: 10.1055/s-0031-1300220. Arzneimittelforschung. 2000. PMID: 10800640

6

Role of Thalidomide on the Expression of OX40, 4-1BB, and GITR in T Cell Subsets.

Kim BS, Kim JY, Kim EJ, Lee JG, Joo DJ, Huh KH, Kim MS, Kim YS. Kim BS, et al. Among authors: kim jy, kim ej, kim ms, kim ys. Transplant Proc. 2016 May;48(4):1270-4. doi: 10.1016/j.transproceed.2015.12.088. Transplant Proc. 2016. PMID: 27320601

7

Gastrointestinal first-pass effect of YJA-20379-8, a new reversible proton pump inhibitor, in rats.

Kim J, Kim EJ, Han KS, Chang MS, Lee MG. Kim J, et al. Among authors: kim ej. J Pharm Pharmacol. 1999 Sep;51(9):1031-6. doi: 10.1211/0022357991773519. J Pharm Pharmacol. 1999. PMID: 10528986

8

Isolation and characterization of cDNAs encoding the vacuolar H(+)-pyrophosphatase of Beta vulgaris.

Kim Y, Kim EJ, Rea PA. Kim Y, et al. Among authors: kim ej. Plant Physiol. 1994 Sep;106(1):375-82. doi: 10.1104/pp.106.1.375. Plant Physiol. 1994. PMID: 7972521 Free PMC article.

9

Satisfaction with mammography in the National Cancer Screening Programme participants of age 40s in Korea.

Jeon BY, Lee HY, Park EC, Choi KS, Jun JK, Kim Y, Han MA, Yoon NH, Kim EJ, Jeon SM. Jeon BY, et al. Among authors: kim ej, kim y. Eur J Cancer Care (Engl). 2011 Nov;20(6):803-9. doi: 10.1111/j.1365-2354.2010.01210.x. Epub 2010 Jul 23. Eur J Cancer Care (Engl). 2011. PMID: 20649810

10

Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect.

Kim EJ, Kim SO, Lee DH, Lim H, Lee MG. Kim EJ, et al. Among authors: kim so. Biopharm Drug Dispos. 2001 Apr;22(3):119-28. doi: 10.1002/bdd.264. Biopharm Drug Dispos. 2001. PMID: 11745914

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,929 results

Search Page

Filters